ストックスクリーナーアプリを入手
445.04
2.14%
9.33
アフターアワーズ：
443.99
-1.05
-0.24%
Vertex Pharmaceuticals Inc (VRTX) 最新ニュース
Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now? - Insider Monkey
Vertex Says Pediatric CASGEVY Data Show Consistent Benefits In Rare Blood Disorders - Benzinga
Vertex CASGEVY pediatric data shows 100% success in CRISPR trials - grafa.com
Zions Bancorporation National Association UT Grows Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Reports Positive Data for Casgevy in Pediatrics - GuruFocus
Illinois Municipal Retirement Fund Reduces Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
LPL Financial LLC Has $125.53 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Presents New Data on CASGEVY ® , Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory Submissions - STT Info
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Vertex Pharmaceuticals stock (US92532F1003): Insider sale draws attention amid strong biotech pipeli - AD HOC NEWS
VRTX: Pipeline momentum in CF, pain, and kidney disease drives innovation-led growth outlook - TradingView
VRTX: Expanding CF, pain, and renal franchises with robust late-stage pipeline and innovation focus - TradingView
Vertex Pharma stock (US92532F1003): focus on cystic fibrosis growth and pipeline potential - AD HOC NEWS
Motley Fool Asset Management LLC Has $10.70 Million Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Motley Fool Wealth Management LLC Decreases Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Franklin Resources Inc. Increases Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Deutsche Bank AG Has $801.94 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Pharmaceuticals (NASDAQ:VRTX) CMO Carmen Bozic Sells 1,745 Shares - MarketBeat
Vertex Pharmaceuticals Insider Sold Shares Worth $785,250, According to a Recent SEC Filing - marketscreener.com
Can Vertex Pharmaceuticals Deepen Its Cystic Fibrosis Edge? - Kalkine Media
O Shaughnessy Asset Management LLC Buys 11,564 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Cerity Partners LLC - MarketBeat
Kyverna vs. Vertex: Clinical-Stage Risk vs. Cash-Flow Stability in Biotech InvestingNews and Statistics - IndexBox
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026? - Yahoo Finance
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026? - The Motley Fool
Membranous Nephropathy Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Roche, BeOne Medicines, Biogen, Vertex Pharma, AstraZeneca, Alexion Pharma, Climb Bio - Barchart.com
News | Not built for eternity: Design technique looks to avoid permanence - CoStar
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference - BioSpace
WINTON GROUP Ltd Purchases New Shares in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Clearbridge Investments LLC Grows Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Capital International Investors Increases Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Capital International Inc. CA Decreases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by TD Asset Management Inc - MarketBeat
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Mixed Recent Returns And Long Term Shareholder Gains - Yahoo Finance
FDA accepts Vertex's BLA for povetacicept in IgA nephropathy - MSN
VRTX Stock Quote Price and Forecast - CNN
Vertex Pharmaceuticals (VRTX) Reveals Promising Cystic Fibrosis Treatment Data - GuruFocus
Carmen R. Bozic sells shares at VRTX (NASDAQ: VRTX) - Stock Titan
Wells Fargo Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $550 - Moomoo
Ixlayer rolls out digital acute pain management platform in collaboration with Vertex Pharmaceuticals - Fierce Healthcare
Harvest Fund Management Co. Ltd Buys 3,527 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Fierce Biotech Layoff Tracker 2026: Fulcrum cuts 85% of staff; Novartis trims research team - Fierce Biotech
Two Beaten-Down Pharma Giants: Biotech’s Cyclical Turn Delivers Prime Dip-Buy Opportunities - NAI500
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Sustained momentum drives Vertex Pharmaceuticals stock higher despite signs of overbought conditions - Traders Union
RBC Capital Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $543 - Moomoo
These 2 Cheap Biotech Stocks Offer Potential for Low-Beta Growth - AOL.com
The Best Stocks to Invest $500 in Right Now - AOL.com
Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10 - BioSpace
Insider Sell: Joy Liu Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
MFS Core Equity Portfolio's Vertex Pharmaceuticals Inc(VRTX) Holding History - GuruFocus
Vertex (VRTX) legal chief sells 828 shares in pre-set 10b5-1 trade - Stock Titan
Vertex Pharma stock (US92532F1003): Insider sale by CMO draws focus as shares hold near recent level - AD HOC NEWS
Vertex (VRTX) Up 0.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Analysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Bicara Therapeutics Inc. (BCAX) - The Globe and Mail
Vertex Pharmaceuticals (VRTX): Company Profile, Stock Price, News, Rankings - Fortune
Vertex Pharmaceuticals Inc Stock (VRTX) Closed Down by 3.03% on Jun 2: Facts Behind the Movement - TradingKey
Vertex stock down nearly 8% in 3 months: Time to buy or stay cautious? - MSN
Madrigal Pharmaceuticals Could Become The Next Vertex - Seeking Alpha
Vertex Pharmaceuticals Inc stock (US92532F1003): shares slip after insider sales and FDA update on p - AD HOC NEWS
Is Vertex Pharmaceuticals (VRTX) Offering An Opportunity After Recent Share Price Consolidation? - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Vertex Pharmaceuticals Insider Sold Shares Worth $888,300, According to a Recent SEC Filing - marketscreener.com
Vertex (VRTX) CMO executes 1,974-share planned sale, retains holdings - Stock Titan
Why is Vertex Pharmaceuticals stock down today? - Traders Union
Should FDA’s IgA Nephropathy BLA Acceptance for Povetacicept Reshape Vertex Pharmaceuticals’ (VRTX) Investment Narrative? - Yahoo Finance
FDA Accepts Vertex's BLA for Povetacicept in IgA Nephropathy - Yahoo Finance
1.63%
0.63%
大文字化:
|
ボリューム (24 時間):